BR0313230A - Uso de carboxamidas para o tratamento de tinido - Google Patents

Uso de carboxamidas para o tratamento de tinido

Info

Publication number
BR0313230A
BR0313230A BR0313230-7A BR0313230A BR0313230A BR 0313230 A BR0313230 A BR 0313230A BR 0313230 A BR0313230 A BR 0313230A BR 0313230 A BR0313230 A BR 0313230A
Authority
BR
Brazil
Prior art keywords
carboxamides
tinnitus treatment
treatment
tinnitus
relates
Prior art date
Application number
BR0313230-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Markus Schmutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0218244A external-priority patent/GB0218244D0/en
Priority claimed from GB0218243A external-priority patent/GB0218243D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0313230A publication Critical patent/BR0313230A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR0313230-7A 2002-08-06 2003-08-05 Uso de carboxamidas para o tratamento de tinido BR0313230A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0218244A GB0218244D0 (en) 2002-08-06 2002-08-06 Organic compounds
GB0218243A GB0218243D0 (en) 2002-08-06 2002-08-06 Organic compounds
PCT/EP2003/008669 WO2004014391A1 (en) 2002-08-06 2003-08-05 Use of carboxamides for the treatment of tinnitus

Publications (1)

Publication Number Publication Date
BR0313230A true BR0313230A (pt) 2005-07-12

Family

ID=31716915

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313230-7A BR0313230A (pt) 2002-08-06 2003-08-05 Uso de carboxamidas para o tratamento de tinido

Country Status (8)

Country Link
US (1) US7465723B2 (https=)
EP (1) EP1528927A1 (https=)
JP (1) JP2005538126A (https=)
CN (1) CN1674909A (https=)
AU (1) AU2003266965A1 (https=)
BR (1) BR0313230A (https=)
CA (1) CA2494660A1 (https=)
WO (1) WO2004014391A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
EP1879590A1 (en) * 2005-05-06 2008-01-23 Portela & Ca., S.A. Eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US9410427B2 (en) * 2012-06-05 2016-08-09 United Technologies Corporation Compressor power and torque transmitting hub
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL125244A (en) 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1528927A1 (en) 2005-05-11
CA2494660A1 (en) 2004-02-19
CN1674909A (zh) 2005-09-28
WO2004014391A1 (en) 2004-02-19
US7465723B2 (en) 2008-12-16
JP2005538126A (ja) 2005-12-15
US20060106009A1 (en) 2006-05-18
WO2004014391B1 (en) 2004-04-15
AU2003266965A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
MXPA03001789A (es) Composiciones para el cuidado de telas que comprenden silicones cationicos y metodos que emplean las mismas.
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE69907977D1 (de) Pyrrolobenzodiazepine
DE60106954D1 (de) Resorcin-derivate
IL224393B (en) Compositions for treatment of huntington&#39;s disease
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
DE60136477D1 (de) Retinoide zur behandlung von emphysem
PT1206436E (pt) Retinoides para o tratamento de enfisema
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
EG23929A (en) Isoxazolines derivatives and their use as antidepressants
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ITMI20010957A0 (it) Derivati dell&#39;aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
SI1475379T1 (sl) Uporaba derivatov skopinskega estra za pripravo zdravil
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2157 DE 08/05/2012.